P/E ratio for DexCom (DXCM)

P/E ratio history for DexCom from 2005 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Edwards Lifesciences EW	27.9	-63.69%	🇺🇸 USA
Becton Dickinson BDX	41.9	-45.47%	🇺🇸 USA
West Pharmaceutical WST	43.7	-43.23%	🇺🇸 USA
Tandem Diabetes Care TNDM	-9.51	-112.37%	🇺🇸 USA
Medtronic MDT	32.6	-57.63%	🇮🇪 Ireland
Abbott Laboratories ABT	39.4	-48.82%	🇺🇸 USA
Johnson & Johnson JNJ	10.9	-85.85%	🇺🇸 USA
QuidelOrtho QDEL	209	171.49%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.